This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $697,198 to the University of California, San Diego (UCSD) to develop a targeted colorectal cancer (CRC) screening strategy for adults aged 45-49. The study aims to: 1) characterize the acceptability of CRC screening in this age group and identify factors influencing screening uptake; and 2) conduct a randomized controlled trial to compare...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $197,640 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop implementation strategies to initiate colorectal cancer (CRC) screening in previously unscreened individuals aged 45 to 54 at a predominantly Black community health center in Boston, Massachusetts. The key objectives are to: (1) identify system-level determinants of...
This $520,177 Project Grant awarded by the U.S. Department of Agriculture (USDA) Rural Utilities Service under the Distance Learning and Telemedicine (DLT) Loans and Grants program (CFDA 10.855) will support telemedicine initiatives to improve access to healthcare services in rural areas of South Carolina. The grant recipient, Caresouth Carolina Inc., a private non-profit health and human services provider, will utilize advanced telecommunications technologies such as computer networks and...
This $637,596 federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) will fund the development and testing of a video-based intervention to reduce defensive colorectal cancer information avoidance and increase screening uptake. The project will conduct a randomized controlled trial to evaluate the intervention's impact on screening intentions and uptake, with a focus on reaching individuals who tend to avoid colorectal cancer...
The National Cancer Institute awarded a $5,151,564 Project Grant under the Cancer Centers Support Grants (CFDA 93.397) program to the Fred Hutchinson Cancer Center in Seattle, WA. The funding supports a Translational Research Program in Colorectal Cancer Disparities (TRPCD) that aims to improve risk-stratified screening, reduce disparities in colorectal cancer mortality, and discover novel therapeutic targets across racially and ethnically diverse populations. The program will conduct four...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research program) provides $670,534 to Northwestern University to develop an innovative optical hyperspectral nanoscale chromatin analysis technology for colorectal cancer (CRC) risk stratification. The goal is to create an accurate, low-cost screening test that can identify patients with advanced adenomas who would benefit from colonoscopy, thereby increasing CRC screening uptake. The...
This federal Project Grant award of $622,913 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will fund a 5-year study to evaluate a multilevel intervention to increase colonoscopic follow-up after abnormal stool-based colorectal cancer screening in a community safety-net setting. The study will be conducted by the University of California, Los Angeles (UCLA) in partnership with the Northeast Valley Health Corporation (NEVHC), a...
This $696,852 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to optimize a mobile messaging intervention for promoting colorectal cancer screening by fecal immunochemical tests (FIT) at community health centers (CHCs). The research, led by the Harvard T.H. Chan School of Public Health, will use a two-phase process to first focus on maximizing patient engagement through optimized text messaging, and then...
This $300,000 Cooperative Agreement award under the Centers for Research and Demonstration for Health Promotion and Disease Prevention program (CFDA 93.135) from the National Center for Chronic Disease Prevention and Health Promotion will support the University of South Carolina in conducting applied public health research focused on cancer prevention and control interventions in South Carolina. The 5-year project will design, implement, and evaluate evidence-based strategies to address...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), will support the development and clinical validation of an Optical Coherence Tomography (OCT) system and two specialized OCT imaging probes to enhance colorectal cancer screening. The $1,471,777 award to The General Hospital Corporation (doing business as Massachusetts General Hospital) aims to create an OCT system that can obtain 3D microscopic images of...